Yumirle Turmelle, M.D., M.S.P.H.  Turmelle_Y@kids.wustl.edu

Associate Professor of Pediatrics, Gastroenterology, Hepatology and Nutrition
Medical Director, Pediatric Liver Transplant Program
Fellowship Program Director, Pediatric Gastroneterology, Hepatology & Nutrition
Fellowship Program Director, Pediatric Transplant Hepatology
Director, Pediatrics Office of Faculty Development
Gastroenterology, Hepatology and Nutrition

phone: (314) 454-6173

Clinical Interests

Biliary Atresia, Neonatal Cholestasis, Pediatric Liver Transplantation

Education

  • AB, with Honors, Miami-Dade Community College1993
  • BA, with Honors, University of Miami1995
  • MD, University of Florida College of Medicine2000
  • MSPH, Saint Louis University2014

Training

  • Resident, University of Miami/Jackson Memorial Hospital2000 - 2003
  • Fellow, Washington University School of Medicine/St. Louis Children's Hospital2003 - 2006
  • Advance Hepatology Fellow, Washington University School of Medicine2006 - 2007

Licensure and Board Certification

  • American Board Certification in Pediatrics 2003
  • American Board Certification in Pediatrics, Pediatric Gastroenterology 2007
  • MO, Physician and Surgeon License 2007
  • American Board Certification in Pediatric Gastroenterology 2007
  • UNOS Certification – Pediatric Liver Transplant Physician 2008
  • American Board Certification in Pediatrics, Pediatric Transplant Hepatology 2010
  • American Board in Pediatric Transplant Hepatology 2010

Honors

  • Thomas Brown McClelland Trust Scholarship, Rotary Foundation of Miami1996 - 2000
  • American Heart Association Summer Student Fellowship Award1997
  • Studies of Pediatric Liver Transplantation (SPLIT) Travel Award2005
  • American Association For The Study of Liver Diseases (AASLD) - Advanced Hepatology Fellowship Award2006
  • American Gastroenterological Association (AGA) Academic Skills Workshop Travel Award2007
  • Washington University School of Medicine Faculty Diversity Grant2007 - 2010

Recent Publications view all (30)


Publication Co-Authors

  1. Liver Transplantation for Malignant Primary Pediatric Hepatic Tumors. J Am Coll Surg. 2017;225(1):103-113. PMID:28232059 
  2. Initial assessment of the infant with neonatal cholestasis-Is this biliary atresia? PLoS One. 2017;12(5):e0176275. PMCID:PMC5426590  PMID:28493866 
  3. Analysis of surgical interruption of the enterohepatic circulation as a treatment for pediatric cholestasis. Hepatology. 2017;65(5):1645-1654. PMCID:PMC5397365  PMID:28027587 
  4. Total Serum Bilirubin within 3 Months of Hepatoportoenterostomy Predicts Short-Term Outcomes in Biliary Atresia. J Pediatr. 2016;170:211-7.e1-2. PMCID:PMC4826612  PMID:26725209 
  5. Quality of Life and Its Determinants in a Multicenter Cohort of Children with Alagille Syndrome. J Pediatr. 2015. doi:10.1016/j.jpeds.2015.04.077  PMID:26059338 
  6. Total serum bilirubin predicts fat-soluble vitamin deficiency better than serum bile acids in infants with biliary atresia. J Pediatr Gastroenterol Nutr. 2014;59(6):702-7. doi:10.1097/MPG.0000000000000547  PMCID:PMC4243585  PMID:25419594 
  7. Medical status of 219 children with biliary atresia surviving long-term with their native livers: results from a North American multicenter consortium. J Pediatr. 2014;165(3):539-546.e2. doi:10.1016/j.jpeds.2014.05.038  PMCID:PMC4144331  PMID:25015575 
  8. Hepatic venous outflow obstruction in pediatric liver transplantation: technical considerations in prevention, diagnosis, and management. Pediatr Transplant. 2014;18(5):497-502. doi:10.1111/petr.12277  PMID:24815309 
  9. Use of corticosteroids after hepatoportoenterostomy for bile drainage in infants with biliary atresia: the START randomized clinical trial. JAMA. 2014;311(17):1750-9. PMCID:PMC4303045  PMID:24794368 
  10. Extrahepatic anomalies in infants with biliary atresia: results of a large prospective North American multicenter study. Hepatology. 2013;58(5):1724-31. doi:10.1002/hep.26512  PMCID:PMC3844083  PMID:23703680 
  11. Health related quality of life in patients with biliary atresia surviving with their native liver. J Pediatr. 2013;163(4):1052-7.e2. PMCID:PMC4014354  PMID:23746866 
  12. Portal hypertension in children and young adults with biliary atresia. J Pediatr Gastroenterol Nutr. 2012;55(5):567-73. doi:10.1097/MPG.0b013e31826eb0cf  PMCID:PMC3483444  PMID:22903006 
  13. Human polyomaviruses in children undergoing transplantation, United States, 2008-2010. Emerg Infect Dis. 2012;18(10):1676-9. doi:10.3201/eid1810.120359  PMCID:PMC3471627  PMID:23017293 
  14. Efficacy of fat-soluble vitamin supplementation in infants with biliary atresia. Pediatrics. 2012;130(3):e607-14. doi:10.1542/peds.2011-1423  PMCID:PMC3428752  PMID:22891232 
  15. Neonatal cholestasis: opportunities to increase early detection. Acad Pediatr. 2012;12(4):283-7. doi:10.1016/j.acap.2012.03.021  PMCID:PMC3398230  PMID:22634076 
  16. Management of excluded bile ducts in paediatric orthotopic liver transplant recipients of technical variant allografts. HPB (Oxford). 2011;13(12):893-8. doi:10.1111/j.1477-2574.2011.00394.x  PMCID:PMC3244630  PMID:22081926 
  17. PedsQL™ Cognitive Functioning Scale in pediatric liver transplant recipients: feasibility, reliability, and validity. Qual Life Res. 2011;20(6):913-21. PMCID:PMC3763499  PMID:21184184 
  18. Small bowel obstruction after pediatric liver transplantation: the unusual is the usual. J Am Coll Surg. 2011;212(1):62-7. doi:10.1016/j.jamcollsurg.2010.09.017  PMID:21123094 
  19. Biliary strictures in pediatric liver transplant recipients - early diagnosis and treatment results in excellent graft outcomes. Pediatr Transplant. 2010;14(3):358-63. doi:10.1111/j.1399-3046.2009.01246.x  PMID:20003138 
  20. The role of liver transplantation for hepatic adenomatosis in the pediatric population: case report and review of the literature. Pediatr Transplant. 2010;14(3):E16-9. doi:10.1111/j.1399-3046.2008.01123.x  PMID:19490491 
  21. Towards minimizing immunosuppression in pediatric liver transplant recipients. Pediatr Transplant. 2009;13(5):553-9. doi:10.1111/j.1399-3046.2008.01061.x  PMID:19067920 
  22. p21 is required for dextrose-mediated inhibition of mouse liver regeneration. Hepatology. 2009;50(1):207-15. doi:10.1002/hep.22979  PMCID:PMC2705473  PMID:19441104 
  23. Serum alpha-NH-butyric acid may predict spontaneous survival in pediatric acute liver failure. Pediatr Transplant. 2009;13(2):223-30. doi:10.1111/j.1399-3046.2008.00998.x  PMCID:PMC2659723  PMID:18643912 
  24. Ibuprofen-induced liver injury in an adolescent athlete. Clin Pediatr (Phila). 2009;48(1):84-6. doi:10.1177/0009922808320797  PMID:18626108 
  25. Evidence for non-traditional activation of complement factor C3 during murine liver regeneration. Mol Immunol. 2008;45(11):3125-32. doi:10.1016/j.molimm.2008.03.008  PMCID:PMC2600895  PMID:18452991 
  26. The effect of recipient-specific surgical issues on outcome of liver transplantation in biliary atresia. Am J Transplant. 2008;8(6):1197-204. doi:10.1111/j.1600-6143.2008.02223.x  PMID:18444930 
  27. Prolonged neonatal jaundice and the diagnosis of biliary atresia: a single-center analysis of trends in age at diagnosis and outcomes. Pediatrics. 2008;121(5):e1438-40. doi:10.1542/peds.2007-2709  PMID:18443020 
  28. Risk factors for rejection and infection in pediatric liver transplantation. Am J Transplant. 2008;8(2):396-403. doi:10.1111/j.1600-6143.2007.02068.x  PMID:18162090 
  29. Biliary atresia: a mostly preventable disease? J Gastroenterol Hepatol. 2008;23(1):3-4. doi:10.1111/j.1440-1746.2007.05235.x  PMID:18171336 
  30. Rosiglitazone inhibits mouse liver regeneration. FASEB J. 2006;20(14):2609-11. doi:10.1096/fj.06-6511fje  PMID:17077279 
Last updated: 08/29/2017
© 2017 by Washington University in St. Louis
One Brookings Drive, St. Louis, MO 63130